Drug Controller General Of India
DCGI issues guidelines for pharma giants manufacturing Covid-19 vaccine
Decoding Feluda: The test that detects Covid-19 quickly, cheaply and easily
Serum Institute gets DCGI nod to resume clinical trial of Oxford vaccine
DCGI aks Serum Institute to suspend recruitment for Oxford vaccine trials
Covid-19: Indian sites await DCGI nod to restart Oxford vaccine trial

Abbott gets DCGI nod for once-a-day heart failure, angina treatment drug
Oxford Covid-19 vaccine trials in India: Serum Institute seeks DCGI nod
Jenburkt Pharma launches Covid-19 drug Favipiravir at Rs 39 per tablet
Cipla gets DCGI approval to sell Covid-19 drug favipiravir in India
We want to price Covid-19 vaccine below Rs 1,000: Serum Institute CEO

FabiFlu cheaper than other drugs to treat Covid-19, claims Glenmark
Glenmark defends pricing of Covid-19 drug FabiFlu, says it is economical
Jubilant Generics gets DCGI nod to manufacture Covid-19 drug Remdesivir
Glenmark under fire for over pricing, 'misguided' claims of Covid-19 drug
Glenmark gets DCGI notice over 'false claims', price of Covid drug FabiFlu
Why vaccines can't be launched overnight
Pharma industry steps up to cure black marketing of Covid-19 drugs
Drug controller approves Biocon's psoriasis drug for emergency Covid-19 use
Mylan gets DGCI nod, to launch generic remdesivir at Rs 4,800 per vial
Covaxin, ZyCov-D trails mark 'beginning of the end' of Covid-19: Scientist